Annotation Detail
Information
- Associated Genes
- STK11
- Associated Variants
-
STK11 LOSS
(
ENST00000326873.12 )
STK11 LOSS ( ENST00000326873.12 ) - Associated Disease
- Peutz-Jeghers syndrome
- Source Database
- CIViC Evidence
- Description
- Preclinical study in a mouse model of Peutz-Jeghers syndrome. Heterozygous Lkb1 (STK11) knockout mice were generated and treated with rapamycin after the onset of polyposis at 9 months of age. Rapamycin treatment significantly suppressed polyposis (p=0.017) and pS6 staining (IHC, p=0.011).
- Variant Origin
- germline
- Variant Origin
- Rare Germline
- Evidence URL
- https://civic.genome.wustl.edu/links/evidence_items/1618
- Gene URL
- https://civic.genome.wustl.edu/links/genes/5534
- Variant URL
- https://civic.genome.wustl.edu/links/variants/485
- Rating
- 1
- Evidence Type
- Predictive
- Disease
- Peutz-Jeghers Syndrome
- Evidence Direction
- Supports
- Drug
- Sirolimus
- Evidence Level
- D
- Clinical Significance
- Sensitivity/Response
- Pubmed
- 18281551
Drugs
Drug Name | Sensitivity | Supported |
---|---|---|
Sirolimus | Sensitivity | true |